Delivery Order SPE2DR25D1202-SPE2DR26F71SD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $8.2K. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,346.74 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (100-count units) with a completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,115.60 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (10-count units). This firm fixed-price delivery order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, represents a non-competitive procurement under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.80 to AmerisourceBergen Drug Corp for Testopel 75 mg pellets on June 11, 2025, with a completion date of July 3, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Testopel is a testosterone replacement therapy product used in hormone treatment applications within military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) valued at $7,968.84 with a firm fixed price structure and no set-aside designation. The contract, issued on November 5, 2025, will be completed by November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Testopel 75 mg pellets valued at $10,289.00. This delivery order, issued on August 25, 2025, represents a firm fixed price contract with performance expected to conclude by September 16, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $7,968.84 to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) on October 22, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $4,115.58 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a $4,115.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) on May 2, 2025, with an ultimate completion date of May 23, 2025. This non-competitive delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,231.20 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (10 units) on September 17, 2025. This competitive, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with fulfillment based at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71SDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $3,984.42. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place of performance and the awardee's headquarters, positioning the company to fulfill this pharmaceutical supply requirement efficiently. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor supporting military and federal healthcare systems worldwide, AmerisourceBergen regularly supplies medications across multiple therapeutic domains including specialty pharmaceuticals and generic drugs. The current award for testosterone pellet therapy demonstrates the company's role in supplying hormone treatments and specialized medical commodities to support Defense Health Agency and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/28/25 |